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Abstract 
Solid pseudopapillary tumor of the pancreas is a rare pancreatic tumor that 
predominantly occurs in young non-Caucasian women. Although most tumors show 
benign behavior, malignant degeneration may occur. A case of solid pseudopapillary 
pancreatic tumor in a Caucasian woman is presented that was investigated by 
endoscopic ultrasonography (EUS), computed tomography, magnetic resonance imaging 
and EUS-guided fine needle aspiration. The patient underwent surgery and radiological 
findings are correlated with histopathology. The preoperative diagnosis of solid 
pseudopapillary tumor of the pancreas is challenging, frequently leading to imaging by 
multiple different modalities. 
 
Introduction 
Solid pseudopapillary tumor (SPT) of the pancreas is a rare enigmatic tumor of low 
malignant potential that most frequently occurs in young non-Caucasian women. 
Although previously suggested, more recent publications have addressed the lack of race 
predominance. Histogenesis is still uncertain and differentiation could be undetermined. 
Most tumors are clinically indolent. After complete resection more than 95% of patients 
are cured. Because of the degenerative changes that commonly accompany these tumors, 
they must be considered in the differential diagnosis with other cystic neoplasms and 
pancreatic pseudocysts. We present a case of SPT in a Caucasian patient investigated by 
endoscopic ultrasonography (EUS), computed tomography (CT) and magnetic resonance  
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imaging (MRI). Radiologic-pathologic correlation is attempted as well as a literature 
review. 
Case Report 
A 32-year-old female Caucasian patient presented to the emergency department of our hospital 
complaining of postprandial epigastric pain during the last 4 months. She had no history of ulcer or any 
other pathology of the upper gastrointestinal tract. Physical examination and laboratory tests were 
unremarkable. Endoscopy of the upper gastrointestinal tract revealed no pathologic findings. The 
patient underwent EUS followed by CT and MRI of the upper abdomen.  
On EUS, a well-circumscribed lesion measuring approximately 3 cm was confirmed in the 
pancreatic body. The lesion presented a mixed solid and cystic composition, with frond-like papillary 
projections into the cystic areas (fig. 1). No surrounding lymphadenopathy was noted, and the 
pancreatic duct appeared to have a normal course and contour. On contrast-enhanced CT, a 
well-circumscribed mass with solid and cystic components was revealed in the pancreatic body. Mild 
enhancement was revealed in the solid parts. The pancreatic duct was slightly dilated in the pancreatic 
tail (fig. 2). All peripancreatic vessels appeared normal. No peripancreatic collections were revealed. 
MRI demonstrated a well-defined lesion with heterogeneous (mixed low and high) signal intensity on 
T1- and T2-weighted images. On T1-weighted image a low intensity area was seen anteriorly. This 
corresponded to a cystic area that was evident on T2-weighted images presenting high signal intensity. 
After contrast administration the lesion enhanced partially and gradually but remained hypointense in 
relation to the normal pancreatic parenchyma (fig. 3). 
The patient underwent EUS-guided fine needle aspiration (EUS-FNA), which revealed a 
homogeneous population of small cells with central ‘grooving’ of the nucleus, a feature characteristic of 
SPT. The cell block revealed a papillary architecture, and immunohistochemical stains on the EUS-FNA 
specimen were strongly positive for vimentin and moderately strongly positive for progesterone 
receptors. The patient then underwent a distal pancreatectomy with preservation of the spleen. 
Intraoperatively there was no evidence of local tumor adhesions with adjacent structures, the mesenteric 
and splenic vessels. The postoperative course was uneventful and she was discharged from hospital after 
6 days of recovery. Six months after the operation the patient is free of disease or any kind of symptoms 
and in excellent general condition. 
At gross examination of the surgical specimen a soft, round, well-circumscribed mass with a 
pseudocapsule was identified. At histologic analysis the tumor was composed of uniform polygonal cells 
arranged in solid nests with areas of cystic degeneration. The cells were separated into pseudopapillary 
aggregates (fig. 4, fig. 5). Areas of old hemorrhage and cholesterol granules were also revealed. No 
vascular or perineural invasion was identified. Three peripancreatic lymph nodes were negative for 
metastasis and showed changes of histiocytic lymphadenitis. 
Immunohistochemical analysis revealed: vimentin (+), NSE (+), progesterone receptors (+), CD10 
mild (+), pankeratin (–), cytokeratin 7 (–), chromogranin A (–), synaptophysin (–), Ki67 2% of the 
neoplastic cells. Diagnosis was consistent with SPT of the pancreas. 
Discussion 
SPT of the pancreas is rare and was first described by Franz in 1959 [1]. Over time 
many terms have been used to describe the same tumor, such as Frantz’s tumor, solid and 
papillary tumor, papillary cystic tumor, solid-cystic tumor, solid-cystic and papillary 
epithelial neoplasm, benign or malignant papillary tumor of the pancreas, papillary 
epithelial neoplasm of pancreas in a child and adenocarcinoma of the pancreas in 
childhood [2]. WHO in 1996 proposed the name ‘solid pseudopapillary tumor’ [3]. This 
term reflects the two most conspicuous histological features: the solid and 
pseudopapillary areas. 
SPTs constitute about 5% of cystic pancreatic tumors and about 1–2% of exocrine 
pancreatic neoplasms. They occur predominantly in girls (not before the age of 9 years)  
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and in younger women (mean age 35 years). There is a predilection for Asian and 
African-American women, but some cases have also been reported in men and children 
[4]. Although most tumors show benign behavior, malignant degeneration may occur. 
These tumors are often older at presentation and have a male predilection [4]. Metastases 
occur most often in the liver [5]. According to WHO classification, SPTs with clear 
criteria of malignancy (vascular and nerve sheath invasion or lymph node and liver 
metastases) are designated as solid pseudopapillary carcinomas. Nevertheless, the tumor 
is indolent, with long patient survival, even in the presence of extension into adjacent 
organs or metastases. Patients are usually asymptomatic. In certain cases the tumor may 
present with a gradually enlarging abdominal mass causing vague abdominal pain or 
discomfort. Obstructive symptoms may occur if the neoplasm grows large enough or is 
located in the pancreatic head. Small tumors are usually incidental findings on abdominal 
imaging studies or during laparotomy performed for other purposes. 
Although SPTs may affect any portion of the pancreas, they are slightly more common 
in the pancreatic tail. This predilection has recently been debated by some authors. In 
some patients they appear as extrapancreatic tumors with only a localized connection to 
the gland [6]. In these cases origin from the pancreas may be difficult to show even at 
surgery [7]. Cases of tumors arising in ectopic pancreatic tissue have also been reported 
[8]. There are no known associations between SPT and other neoplasms or heritable or 
acquired medical conditions. Serum amylase levels and cancer markers (CA19–9, 
carcinoembryonic antigen, α-fetoprotein) are usually normal. They are also not associated 
with paraneoplastic syndromes because of the production of hormones or enzymes by the 
tumor. 
On imaging the combined solid and cystic nature is usually evident. Ultrasonography 
findings have been described in the literature [9]. Well-encapsulated cystic and solid 
masses can be seen, but sometimes SPT may present as a solid-looking mass or having 
internal septa and calcifications. CT usually demonstrates a well-encapsulated lesion with 
varying solid and cystic components owing to hemorrhagic degeneration. Following 
contrast material administration, enhancing solid areas are typically noted at the 
periphery, whereas cystic spaces are usually more centrally located [10]. In our case cystic 
spaces were located in the anterior aspect of the tumor and solid areas in the posterior. In 
some instances large tumors show complete cystic degeneration. The cysts often exhibit 
fluid-debris levels [11]. The presence of a thick peritumoral fibrous capsule results in a 
radiological similarity to pancreatic pseudocysts. 
EUS also typically demonstrates a well-demarcated, encapsulated lesion with mixed 
solid and cystic components. The diagnostic utility of EUS has been greatly augmented by 
the ability to perform fine needle aspiration (EUS-FNA) of the lesion. The specimen 
obtained on EUS-FNA can also be stained immunohistochemically, as was seen in the 
case presented. However, small SPTs may show no cystic changes at all. In these instances 
the radiographic appearance could be similar to that of a pancreatic endocrine neoplasm. 
Areas of high signal intensity on T1-weighted images and low or inhomogeneous signal 
intensity on T2-weighted images can help identify blood products [12]. Moreover SPTs 
do not demonstrate the hypervascularity typically seen in islet cell tumors. 
In our case hemorrhagic areas were not evident in imaging studies. On the initial 
contrast-phase the mass was hypointense but showed progressive filling, a finding that 
has also been described by other authors [4]. Overall, between imaging findings and 
pathology results, there was agreement in the characterization of cystic areas and in the 
presence of a peripheral pseudocapsule.  
Case Rep Gastroenterol 2008;2:486–493 
DOI: 10.1159/000175566 
Published online: December 5, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
489
Although the radiologic features are often informative, significant overlap exists. Fine 
needle aspiration or biopsy and cytologic or histologic analysis are needed for definitive 
diagnosis in certain cases. The cytological features of SPT are highly characteristic [13]. 
On gross examination a solid, cystic, solid-cystic and/or hemorrhagic appearance may be 
possible, depending on tumor size. Histologically SPT is generally characterized by solid 
areas with a pseudopapillary pattern and cystic spaces due to degenerative changes. In 
some cases extensive hemorrhage into the cystic spaces results in the appearance of an 
organized thrombus. A fibrous pseudocapsule surrounding the tumor may be seen. Some 
SPTs may be entirely fibrotic whereas others may be entirely cystic. 
The differential diagnosis includes acinar tumors, pancreatoblastoma and endocrine 
tumors. However the immunohistochemical pattern of SPTs is distinctive and differs 
from that of other primary pancreatic tumors. Cytokeratin expression is rare (in our case 
it was negative) and markers of acinar differentiation are often negative. Presence of 
neuroendocrine markers is not significant (chromogranin A is not detected and 
synaptophysin has a patchy immunoreactivity on 22%) [14]. In our case there was neither 
chromogranin nor synaptophysin expression. 
Different hypotheses of histogenesis of SPTs have been postulated. Many investigators 
favor the theory that SPTs originate from multipotent primordial cells, while others 
suggest an extrapancreatic origin from genital ridges of ovarian-related cells attached to 
pancreatic tissue during early embryogenesis. Some controversies still exist for both 
hypotheses. The presence of progesterone receptors like in our case favors the second 
theory, but SPTs also occur in men without sex hormone abnormalities. A low pool of 
ki67-reactive tumor cells has also been referred, explaining the good clinical outcome of 
these tumors, and was also noticed in our case. 
Patients with SPTs can be adequately managed by pylorus-preserving 
pancreatoduodenectomy or spleen-preserving distal pancreatectomy, as in our case [15]. 
Selected neoplasms of the body can be managed by corpus resection by experienced 
surgeons dedicated in pancreatic surgery. The efficacy of chemotherapy or radiation 
therapy for SPT has yet to be shown, although a single case was reported to be resectable 
after preoperative chemotherapy [16]. 
Noninflammatory cystic lesions of the pancreas are increasingly recognized due to 
enhanced imaging modalities. They comprise a wide range of differing underlying 
pathologies from completely benign through premalignant to frankly malignant. The 
exact diagnostic and management pathway of these lesions remains challenging and 
algorithms for the diagnosis and management have been suggested by the International 
Association of Pancreatology [17, 18]. SPT should be encountered in the differential 
diagnosis of a cystic pancreatic lesion with or without a solid component in young 
patients. 
Conclusion 
In view of the relative benign behavior of SPTs, the young age of patients and the 
complete alleviation of all symptoms after resection, accurate preoperative diagnosis is 
very important. Radiologists should be familiar with typical and atypical presentation of 
SPTs and use all available imaging methods in difficult cases. A team of experienced 
radiologists, gastroenterologists, surgeons and pathologists is essential for the appropriate 
management of these rare tumors.  
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Fig. 1. EUS image shows a heterogeneous lesion in the pancreatic body with hypo- and hyperechoic 
features and cystic areas. 
 
 
 
Fig. 2. Contrast-enhanced CT reveals a well-circumscribed mass with solid and cystic components and 
a small calcification. Mild enhancement is seen in the solid parts. 
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Fig. 3. T2-weighted MR image. The cystic areas in the anterior aspect of the pancreatic lesion are well 
delineated from the solid parts posteriorly. 
 
 
 
 
Fig. 4. SPT of the pancreas on the right side of the figure in association with the normal pancreatic 
parenchyma (HE, ×10). 
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Fig. 5. The papillary pattern of growth and small cysts of the tumor (HE, ×400). 
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